← Eichor
Study identifier: NCT02468024 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Condition: Non-Small Cell Lung Cancer  ·  Sponsor: University of Texas Southwestern Medical Center

PhasePhase 3
Planned participants272
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC

This description comes directly from the study's public registry record.

Talk to the study team

Sarah Neufeld, MBA  ·  214-645-8525  ·  sarah.hardee@UTSouthwestern.edu

Always discuss trial participation with your own doctor first.

Locations (50)

UCSDLa Jolla, California, United StatesCompleted
University of Colorado/MemorialAurora, Colorado, United StatesCompleted
Penrose Cancer CenterColorado Springs, Colorado, United StatesCompleted
Boca Raton Regional HospitalBoca Raton, Florida, United StatesCompleted
Curtis and Elizabeth Anderson CancerSavannah, Georgia, United StatesRecruiting
University of IowaIowa City, Iowa, United StatesTerminated
University of Kansas Medical CenterKansas City, Kansas, United StatesCompleted
University of Kentucky Health CareLexington, Kentucky, United StatesCompleted
University of Louisville PhysiciansLouisville, Kentucky, United StatesActive Not Recruiting
Ochsner Medical CenterNew Orleans, Louisiana, United StatesCompleted
Luminis Health Research InstituteAnnapolis, Maryland, United StatesActive Not Recruiting
University of Maryland Medical CenterBaltimore, Maryland, United StatesCompleted

+ 38 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02468024